Seelos Therapeutics Inc (SEEL)

[eicoman]

I agree RVL, this first of a kind meeting was significant, in the the 2 day meeting I listened to, the FDA really appeared incompetent and out of date on this issue compared to experts and public advocacy groups, I'm not denying it will take time, but an approval of Flibanserin in the spring should get Femprox partnering moving again with a start for PH3 trials in the EU. The EMA is more progressive on this issue, plus Vitaros is already approved and selling there with positive patient results. Seems to me the USA will take a while for Femprox but the EU is still a significant market that could happen much sooner. everyone here should sign the petition http://eventhescore.org